Business
Public Accounts Committee Reveals Taxpayer Dollars Funneled to Liberal Insiders with No Accountability
																								
												
												
											Public Accounts Committee reveals SDTC’s rampant conflicts of interest, lack of oversight, and millions in taxpayer dollars benefiting insiders—while Liberal MPs defend Trudeau’s “green” slush fund.
What happens when politicians promise “green energy” but deliver taxpayer-funded corruption? If you tuned in to Canada’s Public Accounts Committee this week, you found out. On the hot seat was Sustainable Development Technology Canada (SDTC), a bloated agency supposedly designed to fund sustainable technology but apparently also set up as a welfare program for ethically dubious board members.
Now, SDTC isn’t some fledgling startup or small-time charity. This agency is sitting on $330 million of your money – Canadian taxpayer money. And what did Canada’s Auditor General find in her investigation? An unbelievable 186 conflicts of interest. That’s not an organization with a few bad apples; that’s a systematic problem.
So why isn’t anyone doing anything? Here’s where it gets even more outrageous. Enter Ethics Commissioner Konrad von Finkelstein, a man whose entire job is to hold officials accountable for ethical breaches. Did he step up to expose the corruption in SDTC? Not really. Von Finkelstein told the committee that his role is simply to “expose” conflicts of interest, not to actually do anything about them. Think about that. Here’s a man whose salary is funded by taxpayers, and his job description basically amounts to reading out loud the names of people breaking the rules.
Conservative MP Michael Cooper wasn’t having it. Cooper laid it out for von Finkelstein, practically begging him to explain why only two out of dozens of SDTC board members were investigated. But von Finkelstein’s excuse? He couldn’t bother because – get this – the Auditor General had already done the hard work. If that sounds like passing the buck, it’s because it is. Canadians aren’t paying for an Ethics Commissioner to sit back and watch. They’re paying for an official who’s supposed to defend the integrity of public institutions. But that’s clearly not happening here.
Liberal Apologists at Work
Not everyone on the committee wanted answers, though. Some were too busy defending SDTC’s “noble” cause. Liberal MP Nathaniel Erskine-Smith practically bent over backward trying to downplay the whole thing. When Conservative MPs called SDTC a “green slush fund,” Erskine-Smith got indignant. He insisted that SDTC wasn’t a criminal organization and took offense at the term “slush fund.” Really? Because if funneling millions of public dollars into the hands of connected board members isn’t a slush fund, I don’t know what is.
Let’s call it what it is. While Erskine-Smith was busy defending SDTC’s “mission,” the committee heard exactly how that mission was carried out – through unethical, undisclosed conflicts of interest, with board members giving funds to companies they had direct financial ties to. And what did Erskine-Smith call this? Just a “few ethical lapses,” as if millions of taxpayer dollars being handed out without oversight is a minor paperwork error.
The Ethics Commissioner’s Toothless Office
Bloc MP Nathalie Sinclair-Desgagné and NDP MP Richard Cannings pressed von Finkelstein on his office’s glaring lack of oversight. Why was he investigating just two board members when nearly 200 conflicts of interest were flagged? His answer was almost laughable: His office couldn’t enforce anything, couldn’t recoup the wasted money, and couldn’t even stop the bleeding of taxpayer funds because his role is “limited.” Limited? That’s putting it lightly.
And here’s where it gets even more insulting. Von Finkelstein admitted that he wouldn’t coordinate with other agencies like the RCMP or the Auditor General to go after these ethical lapses. This office, which exists solely to enforce ethical standards, can’t or won’t go after those breaking them. It’s as if the Ethics Commissioner’s job is to stand back and announce that something unethical happened, only to shrug and do nothing about it. Can you imagine running any organization that way? Of course not – but in the Canadian government, this seems to be the new normal.
Auditor Testifies, and It’s Worse Than We Thought
Just when we thought the Ethics Commissioner’s testimony had exposed the worst of Canada’s green-tech “accountability” disaster, along comes Auditor General official Michel Bédard. You’d think with the staggering amount of taxpayer money SDTC has under its control, someone would be keeping tabs. But if today’s testimony proved anything, it’s that this agency has zero meaningful oversight, a culture that actively ignores conflicts of interest, and no one stepping in to protect Canadians’ hard-earned money.
So, here we go again. 186 conflicts of interest, millions in public funds granted to companies with ties to board members—SDTC is basically the Wild West of “green” government spending. And guess what? Just like the Ethics Commissioner, Bédard’s office can report on it, but he admitted they can’t actually do anything to stop it. All that money might as well be floating in a pool, with insiders diving in for their share.
The “Accountability” Problem: Michael Cooper’s Pointed Questions
Conservative MP Michael Cooper wasn’t here to play around. He honed in on the obvious question: if SDTC’s board members aren’t held accountable, what’s the point of an Auditor General report? Cooper pushed Bédard to explain why these SDTC board members weren’t facing any real consequences. Bédard’s response? His office doesn’t have the authority to penalize or recover funds—it’s all just for show. That’s the message, folks: this is a government program that “monitors” ethical breaches but has no teeth.
If you’re wondering why SDTC board members feel free to treat taxpayers’ dollars like a bottomless well, this is it. They know that nothing’s going to happen. Cooper hit the nail on the head when he called out the lack of deterrence, and Canadians ought to be asking: why are we funding oversight bodies that can’t actually hold people accountable?
Liberals Try to Soften the Blow—Iqra Khalid’s Flimsy Defense
Then, enter Liberal MP Iqra Khalid, swooping in with damage control. Her goal? To downplay this mess as if it’s all just a big misunderstanding. She floated the idea that SDTC’s ethical violations weren’t “intentional misconduct” but simply lapses in judgment, suggesting board members maybe didn’t “understand” conflict-of-interest rules. Are we supposed to believe that these seasoned board members—handling millions in taxpayer funds—just forgot their ethics training?
Khalid hinted that more “training” and “internal guidance” would fix things. Bédard’s subtle response was telling: yes, training is helpful, but let’s be clear, SDTC’s issues are deeper. It’s a cultural problem within an organization that has no incentive to follow the rules. Training can’t fix a system that fundamentally disregards ethical standards. Khalid’s attempt to sidestep accountability only underscored what’s really happening here—a refusal to impose consequences.
Nathalie Sinclair-Desgagné and Richard Cannings: Why Aren’t Taxpayers Being Compensated?
Bloc Québécois MP Nathalie Sinclair-Desgagné and NDP MP Richard Cannings brought up the most glaring issue yet: where’s the money? Taxpayers are funding SDTC, watching it go straight into the hands of conflicted board members, and yet, there’s no mechanism to get that money back. Sinclair-Desgagné demanded answers on why SDTC couldn’t recoup funds that were misappropriated due to these ethical lapses. Bédard’s response? The Auditor General’s office has no authority to force financial recovery, meaning SDTC’s board can make conflicted decisions with no risk of losing the cash.
Cannings and Sinclair-Desgagné went further, questioning whether anything less than legislative reform could solve this crisis. It was clear that these MPs understood the root of the problem: SDTC’s oversight is built on a house of cards, with taxpayer money at stake and no tools to hold anyone accountable. Canadians are effectively writing blank checks to a board of insiders who profit without consequences.
The Big Picture: A Culture of Entitlement and Zero Accountability
Michel Bédard’s testimony laid bare the sickening entitlement within SDTC’s leadership. This isn’t a minor oversight or an accidental misunderstanding—this is a systemic culture where people with a financial stake in the projects can vote themselves money, and no one bats an eye. Worse, the Liberal defense of SDTC is that because it has a “green mission,” its failures somehow don’t matter. They’re telling Canadians that as long as the organization’s purpose sounds virtuous, the rules don’t apply.
Let’s be real. No one believes that SDTC’s board members are unaware of basic ethics rules. These are people who sit in decision-making positions, who know full well the implications of conflict of interest. What’s happened here is that they’re taking advantage of a system that has no means of holding them accountable, and they know it.
What Canada Needs Now, Real Accountability, Not Empty Promises
The real takeaway from Bédard’s testimony? Canada’s so-called oversight framework is a farce. The Trudeau government has set up an accountability structure that looks good on paper but doesn’t stop the political class from dipping their hands in taxpayer money. If we want to see real change, Canadians need a complete overhaul of the system—one that actually empowers the Auditor General and Ethics Commissioner to take action and enforce consequences, not just to “report” and move on. Until that happens, SDTC will keep doing what it does best: functioning as a de facto slush fund for Trudeau’s elite insiders, where conflicts of interest are not exceptions but the rule.
Canadians deserve far better than a government handing out their tax dollars to political friends who think they’re untouchable. Michel Bédard’s testimony laid bare SDTC’s blatant failures, and it’s a moment of reckoning. Will any of these politicians rise above the corruption and demand real reform? Or will this testimony be just another chapter in the Trudeau government’s long saga of accountability failures?
Let’s get one thing straight: this isn’t about “green energy” or “sustainability.” Those are just fancy words bureaucrats use while they funnel public money to friends and business associates without a shred of oversight. And here’s the kicker—Liberal MPs want Canadians to think this is just a “misunderstanding” or, worse, that questioning it is somehow unpatriotic. It’s the Trudeau swamp at its finest: shut down accountability by slapping a green label on taxpayer-funded corruption and hoping no one notices.
Let’s face it: Sustainable Development Technology Canada isn’t operating in some dark corner of bureaucracy. It’s operating right out in the open, with the full backing of Trudeau’s government, while the Ethics Commissioner, the Auditor General, and Liberal MPs play the role of political apologists, doing everything they can to sweep this rot under the rug.
This committee session showed Canadians one thing loud and clear: they’re being lied to. Told that their money is supporting green technology, but instead, it’s being pocketed by insiders. SDTC, the Ethics Commissioner, the Auditor General—they’re not protecting Canadians. They’re protecting the interests of a political class that’s putting cronyism above the public good.
In a fair system, people would lose their jobs over this. Taxpayer money would be repaid. And those who let SDTC slip through the cracks would face consequences. But in Trudeau’s Canada, officials hide behind excuses, Ethics Commissioners wring their hands about “exposure,” and Liberal MPs get offended when we dare call corruption for what it is.
This isn’t “oversight.” It’s an insult to every Canadian who funds this government. It’s time to drain the Trudeau swamp, end the era of unchecked cronyism, and demand real, accountable governance. Canadians deserve nothing less.
Subscribe to The Opposition with Dan Knight .
Brownstone Institute
Bizarre Decisions about Nicotine Pouches Lead to the Wrong Products on Shelves
														From the Brownstone Institute
A walk through a dozen convenience stores in Montgomery County, Pennsylvania, says a lot about how US nicotine policy actually works. Only about one in eight nicotine-pouch products for sale is legal. The rest are unauthorized—but they’re not all the same. Some are brightly branded, with uncertain ingredients, not approved by any Western regulator, and clearly aimed at impulse buyers. Others—like Sweden’s NOAT—are the opposite: muted, well-made, adult-oriented, and already approved for sale in Europe.
Yet in the United States, NOAT has been told to stop selling. In September 2025, the Food and Drug Administration (FDA) issued the company a warning letter for offering nicotine pouches without marketing authorization. That might make sense if the products were dangerous, but they appear to be among the safest on the market: mild flavors, low nicotine levels, and recyclable paper packaging. In Europe, regulators consider them acceptable. In America, they’re banned. The decision looks, at best, strange—and possibly arbitrary.
What the Market Shows
My October 2025 audit was straightforward. I visited twelve stores and recorded every distinct pouch product visible for sale at the counter. If the item matched one of the twenty ZYN products that the FDA authorized in January, it was counted as legal. Everything else was counted as illegal.
Two of the stores told me they had recently received FDA letters and had already removed most illegal stock. The other ten stores were still dominated by unauthorized products—more than 93 percent of what was on display. Across all twelve locations, about 12 percent of products were legal ZYN, and about 88 percent were not.
The illegal share wasn’t uniform. Many of the unauthorized products were clearly high-nicotine imports with flashy names like Loop, Velo, and Zimo. These products may be fine, but some are probably high in contaminants, and a few often with very high nicotine levels. Others were subdued, plainly meant for adult users. NOAT was a good example of that second group: simple packaging, oat-based filler, restrained flavoring, and branding that makes no effort to look “cool.” It’s the kind of product any regulator serious about harm reduction would welcome.
Enforcement Works
To the FDA’s credit, enforcement does make a difference. The two stores that received official letters quickly pulled their illegal stock. That mirrors the agency’s broader efforts this year: new import alerts to detain unauthorized tobacco products at the border (see also Import Alert 98-06), and hundreds of warning letters to retailers, importers, and distributors.
But effective enforcement can’t solve a supply problem. The list of legal nicotine-pouch products is still extremely short—only a narrow range of ZYN items. Adults who want more variety, or stores that want to meet that demand, inevitably turn to gray-market suppliers. The more limited the legal catalog, the more the illegal market thrives.
Why the NOAT Decision Appears Bizarre
The FDA’s own actions make the situation hard to explain. In January 2025, it authorized twenty ZYN products after finding that they contained far fewer harmful chemicals than cigarettes and could help adult smokers switch. That was progress. But nine months later, the FDA has approved nothing else—while sending a warning letter to NOAT, arguably the least youth-oriented pouch line in the world.
The outcome is bad for legal sellers and public health. ZYN is legal; a handful of clearly risky, high-nicotine imports continue to circulate; and a mild, adult-market brand that meets European safety and labeling rules is banned. Officially, NOAT’s problem is procedural—it lacks a marketing order. But in practical terms, the FDA is punishing the very design choices it claims to value: simplicity, low appeal to minors, and clean ingredients.
This approach also ignores the differences in actual risk. Studies consistently show that nicotine pouches have far fewer toxins than cigarettes and far less variability than many vapes. The biggest pouch concerns are uneven nicotine levels and occasional traces of tobacco-specific nitrosamines, depending on manufacturing quality. The serious contamination issues—heavy metals and inconsistent dosage—belong mostly to disposable vapes, particularly the flood of unregulated imports from China. Treating all “unauthorized” products as equally bad blurs those distinctions and undermines proportional enforcement.
A Better Balance: Enforce Upstream, Widen the Legal Path
My small Montgomery County survey suggests a simple formula for improvement.
First, keep enforcement targeted and focused on suppliers, not just clerks. Warning letters clearly change behavior at the store level, but the biggest impact will come from auditing distributors and importers, and stopping bad shipments before they reach retail shelves.
Second, make compliance easy. A single-page list of authorized nicotine-pouch products—currently the twenty approved ZYN items—should be posted in every store and attached to distributor invoices. Point-of-sale systems can block barcodes for anything not on the list, and retailers could affirm, once a year, that they stock only approved items.
Third, widen the legal lane. The FDA launched a pilot program in September 2025 to speed review of new pouch applications. That program should spell out exactly what evidence is needed—chemical data, toxicology, nicotine release rates, and behavioral studies—and make timely decisions. If products like NOAT meet those standards, they should be authorized quickly. Legal competition among adult-oriented brands will crowd out the sketchy imports far faster than enforcement alone.
The Bottom Line
Enforcement matters, and the data show it works—where it happens. But the legal market is too narrow to protect consumers or encourage innovation. The current regime leaves a few ZYN products as lonely legal islands in a sea of gray-market pouches that range from sensible to reckless.
The FDA’s treatment of NOAT stands out as a case study in inconsistency: a quiet, adult-focused brand approved in Europe yet effectively banned in the US, while flashier and riskier options continue to slip through. That’s not a public-health victory; it’s a missed opportunity.
If the goal is to help adult smokers move to lower-risk products while keeping youth use low, the path forward is clear: enforce smartly, make compliance easy, and give good products a fair shot. Right now, we’re doing the first part well—but failing at the second and third. It’s time to fix that.
Addictions
The War on Commonsense Nicotine Regulation
														From the Brownstone Institute
Cigarettes kill nearly half a million Americans each year. Everyone knows it, including the Food and Drug Administration. Yet while the most lethal nicotine product remains on sale in every gas station, the FDA continues to block or delay far safer alternatives.
Nicotine pouches—small, smokeless packets tucked under the lip—deliver nicotine without burning tobacco. They eliminate the tar, carbon monoxide, and carcinogens that make cigarettes so deadly. The logic of harm reduction couldn’t be clearer: if smokers can get nicotine without smoke, millions of lives could be saved.
Sweden has already proven the point. Through widespread use of snus and nicotine pouches, the country has cut daily smoking to about 5 percent, the lowest rate in Europe. Lung-cancer deaths are less than half the continental average. This “Swedish Experience” shows that when adults are given safer options, they switch voluntarily—no prohibition required.
In the United States, however, the FDA’s tobacco division has turned this logic on its head. Since Congress gave it sweeping authority in 2009, the agency has demanded that every new product undergo a Premarket Tobacco Product Application, or PMTA, proving it is “appropriate for the protection of public health.” That sounds reasonable until you see how the process works.
Manufacturers must spend millions on speculative modeling about how their products might affect every segment of society—smokers, nonsmokers, youth, and future generations—before they can even reach the market. Unsurprisingly, almost all PMTAs have been denied or shelved. Reduced-risk products sit in limbo while Marlboros and Newports remain untouched.
Only this January did the agency relent slightly, authorizing 20 ZYN nicotine-pouch products made by Swedish Match, now owned by Philip Morris. The FDA admitted the obvious: “The data show that these specific products are appropriate for the protection of public health.” The toxic-chemical levels were far lower than in cigarettes, and adult smokers were more likely to switch than teens were to start.
The decision should have been a turning point. Instead, it exposed the double standard. Other pouch makers—especially smaller firms from Sweden and the US, such as NOAT—remain locked out of the legal market even when their products meet the same technical standards.
The FDA’s inaction has created a black market dominated by unregulated imports, many from China. According to my own research, roughly 85 percent of pouches now sold in convenience stores are technically illegal.
The agency claims that this heavy-handed approach protects kids. But youth pouch use in the US remains very low—about 1.5 percent of high-school students according to the latest National Youth Tobacco Survey—while nearly 30 million American adults still smoke. Denying safer products to millions of addicted adults because a tiny fraction of teens might experiment is the opposite of public-health logic.
There’s a better path. The FDA should base its decisions on science, not fear. If a product dramatically reduces exposure to harmful chemicals, meets strict packaging and marketing standards, and enforces Tobacco 21 age verification, it should be allowed on the market. Population-level effects can be monitored afterward through real-world data on switching and youth use. That’s how drug and vaccine regulation already works.
Sweden’s evidence shows the results of a pragmatic approach: a near-smoke-free society achieved through consumer choice, not coercion. The FDA’s own approval of ZYN proves that such products can meet its legal standard for protecting public health. The next step is consistency—apply the same rules to everyone.
Combustion, not nicotine, is the killer. Until the FDA acts on that simple truth, it will keep protecting the cigarette industry it was supposed to regulate.
- 
																	
										
																			Business2 days agoTrans Mountain executive says it’s time to fix the system, expand access, and think like a nation builder
 - 
																	
										
																			International2 days agoBiden’s Autopen Orders declared “null and void”
 - 
																	
										
																			MAiD2 days agoStudy promotes liver transplants from Canadian euthanasia victims
 - 
																	
										
																			Business2 days agoCanada has given $109 million to Communist China for ‘sustainable development’ since 2015
 - 
																	
										
																			Internet2 days agoMusk launches Grokipedia to break Wikipedia’s information monopoly
 - 
																	
										
																			Business2 days agoCanada’s combative trade tactics are backfiring
 - 
																	
										
																					Environment1 day agoThe era of Climate Change Alarmism is over
 - 
																	
										
																			Automotive2 days agoCarney’s Budget Risks Another Costly EV Bet
 










